Product Description
Experience the preeminent solution for osteoarthritis knee pain with MONOVISC INJECTION, formulated with high molecular weight sodium hyaluronate (1.0 to 2.9 million Daltons) in a 4 ml sterile, latex-free pre-filled syringe. This outstanding, high viscosity gel forms a commanding viscoelastic cushion within the joint space, providing targeted relief through a single, easy intra-articular injection. Grab this CE-marked and US FDA 510k-approved product, sterilized via aseptic filtering and terminal sterilization, for adults only. Specially designed for safety, biocompatibility, and top clinical performance, it is ready to use and non-toxic.
MONOVISC INJECTION: Competitive Edge in Joint Care
MONOVISC INJECTION boasts exceptional efficacy with its high molecular weight hyaluronan and single-use, pre-filled syringe for a seamless intra-articular administration. Its high viscoelasticity and outstanding biocompatibility ensure optimal patient outcomes. The injection is ready-to-use, sterile, and latex-free, reflecting the commanding features of advanced viscosupplementation therapy for joint pain in adults. This special device is CE-marked and US FDA-approved, affirming its top-tier reliability for both practitioners and patients in the orthopedic segment.
MONOVISC INJECTION: Sample Availability and Export Capabilities
A sample of MONOVISC INJECTION may be supplied for evaluation purposes upon request. Our top-quality product is primarily exported to leading international markets, including distributors, wholesalers, and suppliers, with a strong presence in India. We offer commanding supply ability and prompt quotation exchanges to ensure swift procurement. As a dedicated exporter and trader, we guarantee steady inventory, secure packaging, and compliance with all import-export regulations for seamless global distribution.
FAQs of MONOVISC INJECTION:
Q: How is MONOVISC INJECTION administered for maximum benefit?
A: MONOVISC INJECTION is delivered as a single intra-articular injection directly into the knee joint by a qualified healthcare professional. This method offers targeted pain relief for adults with osteoarthritis.
Q: What makes MONOVISC INJECTION a special treatment in viscosupplementation therapy?
A: It features high molecular weight hyaluronan in a pre-filled, latex-free syringe, providing significant viscoelasticity for cushioning joints. The treatment is CE-marked, US FDA-approved, and requires only one injection per treatment course.
Q: When should MONOVISC INJECTION be avoided?
A: Avoid its use in patients with hypersensitivity to hyaluronan products or if there is an active infection at the proposed injection site.
Q: Where is MONOVISC INJECTION manufactured and exported?
A: MONOVISC INJECTION is usually manufactured in the USA or Canada and is widely distributed and exported globally, including India and other major markets.
Q: What is the process for storing and disposing of MONOVISC INJECTION?
A: Store MONOVISC INJECTION at 2C to 25C, away from freezing. Properly dispose of used syringes in accordance with local medical waste guidelines.
Q: How does the outstanding viscoelasticity of MONOVISC INJECTION improve joint function?
A: The high viscosity, gel-forming sodium hyaluronate cushions and lubricates the joint space, reducing pain and enhancing movement in osteoarthritic knees.